P R Dal Monte, N D'Imperio, G Formica, S Macchia, A Piemontese, F Sarti, P Spongano
{"title":"[生长抑素(VAL 787)治疗上消化道出血的临床评价]。","authors":"P R Dal Monte, N D'Imperio, G Formica, S Macchia, A Piemontese, F Sarti, P Spongano","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Personal experience with 30 patients treated with Somatostatin for upper gastrointestinal bleeding is reported. The conclusion is drawn that this drug, reducing chloro-peptic secretion and hepatic portal blood flow, can reduce and control bleeding and postpone the surgical operation, which has a high rate of mortality.</p>","PeriodicalId":18687,"journal":{"name":"Minerva dietologica e gastroenterologica","volume":"35 4","pages":"261-4"},"PeriodicalIF":0.0000,"publicationDate":"1989-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Clinical evaluation of the use of somatostatin (VAL 787) in the treatment of upper digestive hemorrhage].\",\"authors\":\"P R Dal Monte, N D'Imperio, G Formica, S Macchia, A Piemontese, F Sarti, P Spongano\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Personal experience with 30 patients treated with Somatostatin for upper gastrointestinal bleeding is reported. The conclusion is drawn that this drug, reducing chloro-peptic secretion and hepatic portal blood flow, can reduce and control bleeding and postpone the surgical operation, which has a high rate of mortality.</p>\",\"PeriodicalId\":18687,\"journal\":{\"name\":\"Minerva dietologica e gastroenterologica\",\"volume\":\"35 4\",\"pages\":\"261-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva dietologica e gastroenterologica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva dietologica e gastroenterologica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Clinical evaluation of the use of somatostatin (VAL 787) in the treatment of upper digestive hemorrhage].
Personal experience with 30 patients treated with Somatostatin for upper gastrointestinal bleeding is reported. The conclusion is drawn that this drug, reducing chloro-peptic secretion and hepatic portal blood flow, can reduce and control bleeding and postpone the surgical operation, which has a high rate of mortality.